Innovent Biologics, Inc. (01801.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 96.55

From 52W high−12.02%

Volume11.85M

Market capHKD 87.80B

P/E (TTM)116.7x

P/S (TTM)4.8x

Div yield—

Key dataSep 18, 2026

Open

HKD 96.55

From 52W high

−12.02%

Volume

11.85M

Market cap

HKD 87.80B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

21.9x

P/E (TTM)

116.7x

RSI (14)

48.2

MomentumView details →

1D Return

+0.47%

YTD Return

+26.69%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

116.7x

EV/EBITDA

21.9x

EV/Sales

3.7x

P/S (TTM)

4.8x

P/B (TTM)

3.6x

ProfitabilityView details →

Gross Margin

80.96%

Net Margin

7.80%

EBITDA Margin

16.85%

ROE (TTM)

5.86%

ROA (TTM)

2.92%

Asset Turnover

0.39x

GrowthView details →

Revenue YoY

+36.46%

EPS YoY

+5.66%

FCF YoY

+479.13%

Revenue CAGR 3Y

+41.98%

EPS CAGR 3Y

+926.16%

EBITDA YoY

+297.45%

MomentumView details →

1D Return

+0.47%

YTD Return

+26.69%

1Y Return

+4.94%

RSI (14)

48.2

vs 50D SMA

+0.96%

vs 200D SMA

+11.01%

Capital & dividendView details →

Debt/Equity

0.11x

Current Ratio

2.68x

Quick Ratio

2.48x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

HKD 0.81

EPS Surprise

49.08%

Beats (12Q)

1/12

Next Q EPS Est

—

Avg Surprise (4Q)

49.08%

Rev Surprise

−3.28%

Financials snapshotView financials →

Revenue (TTM)

27.01B

Net Income (TTM)

2.35B

Op. CF (TTM)

11.60B

Next earningsMar 31, 2027 →

Latest newsMore news →

Hong Kong stocks closed higher on September 14, 2026, with the Hang Seng Index up 111 points or 0.5% at 24,917, while the Hang Seng Tech Index slipped 2 points or 0.1% to 4,317 and the China Enterprises Index rose 38 points or 0.5% to 8,284 on turnover of HK$192.625 billion.7d ago

Innovent Biologics' Suzhou manufacturing base passed an on-site GMP inspection by the European Medicines Agency and obtained an EU GMP certificate.14d ago

Similar companies

Genscript Biotech Corporation01548.HK Akeso, Inc.09926.HK Regeneron Pharmaceuticals, Inc.REGN Sino Biopharmaceutical Limited01177.HK MedPacto, Inc.235980.KQ Vaxcell-Bio Therapeutics Co., Ltd.323990.KQ Find similar companies →

Latest newsMore news →

Hong Kong stocks closed higher on September 14, 2026, with the Hang Seng Index up 111 points or 0.5% at 24,917, while the Hang Seng Tech Index slipped 2 points or 0.1% to 4,317 and the China Enterprises Index rose 38 points or 0.5% to 8,284 on turnover of HK$192.625 billion.7d ago Innovent Biologics' Suzhou manufacturing base passed an on-site GMP inspection by the European Medicines Agency and obtained an EU GMP certificate.14d ago